Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-26

Clinical Trial Update: Effects of Mepivacaine on the Neurological Sequelae of Cerebral Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effects of mepivacaine on neurological sequelae after ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mepivacaine (mepivacaine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ischemic Stroke | Phase 2 | Status: UNKNOWN